Patent intelligence · US
US 2009326434
Anti-Microbial Photodynamic Therapy
Anti-Microbial Photodynamic Therapy
Patent details — US 2009326434
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 31, 2009
- Expiration
- Dec 26, 2029
- Applicant
- NIFANTIEV NIKOLAY E [RU]
- CPC classes
- A61K 31/ 407 A I, A61K 31/ 7088 A I, A61K 41/ 00 A I, A61K 47/ 48 A I
Quick answer
US 2009326434 (Anti-Microbial Photodynamic Therapy) is held by NIFANTIEV NIKOLAY E [RU]. Status: granted. Granted Dec 31, 2009. Expires Dec 26, 2029 (4 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- NIFANTIEV NIKOLAY E [RU]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 407 A I, A61K 31/ 7088 A I, A61K 41/ 00 A I, A61K 47/ 48 A I, A61K/31407, A61K/410071
More from NIFANTIEV NIKOLAY E [RU]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
granted -
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
granted
Frequently asked questions
What is US patent 2009326434?
US 2009326434 (Anti-Microbial Photodynamic Therapy) is held by NIFANTIEV NIKOLAY E [RU]. Status: granted. Granted Dec 31, 2009. Expires Dec 26, 2029 (4 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2009326434?
NIFANTIEV NIKOLAY E [RU] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2009326434 expire?
Our index shows an expiration date of Dec 26, 2029 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.